Persones / Equip Humà

Andrés Morales la Madrid

Buscador de publicacions

Publicacions

  • van Zanten SE, Baugh J, Chaney B, De Jongh D, Aliaga ES, Barkhof F, Noltes J, De Wolf R, Van Dijk J, Cannarozzo A, Damen-Korbijn CM, Lieverst JA, Colditz N, Hoffmann M, Warmuth-Metz M, Bison B, Jones DT, Sturm D, Gielen GH, Jones C, Hulleman E, Calmon R, Castel D, Varlet P, Giraud G, Slavc I, Van Gool S, Jacobs S, Jadrijevic-Cvrlje F, Sumerauer D, Nysom K, Pentikainen V, Kivivuori SM, Leblond P, Entz-Werle N, von Bueren AO, Kattamis A, Hargrave DR, Hauser P, Garami M, Thorarinsdottir HK, Pears J, Gandola L, Rutkauskiene G, Janssens GO, Torsvik IK, Perek-Polnik M, Gil-da-Costa MJ, Zheludkova O, Shats L, Deak L, Kitanovski L, Cruz-Martínez O, Morales-La Madrid A, Holm S, Gerber N, Kebudi R, Grundy R, Lopez-Aguilar E, Zapata-Tarres M, Emmerik J, Hayden T, Bailey S, Biassoni V, Massimino M, Grill J, Vandertop WP, Kaspers GJ, Fouladi M, Kramm CM, van Vuurden DG and members of the SIOPE DIPG Network.

    Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease.

    JOURNAL OF NEURO-ONCOLOGY . 132(2): 255-266. Nº de cites: 39

    [doi:10.1007/s11060-016-2363-y]

  • Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, Benghiat H, Hoeben B, Morales-La Madrid A, Kortmann RD, Hargrave D, Menten J, Pecori E, Biassoni V, von Bueren AO, van Vuurden DG, Massimino M, Sturm D, Peters M and Kramm CM.

    Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.

    EUROPEAN JOURNAL OF CANCER . 73: 38-47. Nº de cites: 90

    [doi:10.1016/j.ejca.2016.12.007]

  • Greenfield JP, Castañeda A, George E, Kieran MW and Morales-La Madrid A.

    Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France

    PEDIATRIC BLOOD & CANCER . 63(12): 2072-2077. Nº de cites: 17

    [doi:10.1002/pbc.26169]

  • Zacharoulis S, Morales-La Madrid A, Bandopadhayay P, Chi SN, Manley P, Ullrich NN, Marcus K, Goumnerova L, Scott RM, Proctor M, Young-Poussaint T, De Girolami U and Kieran MW.

    Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 38(6): 479-485. Nº de cites: 10

    [doi:10.1097/MPH.0000000000000627]

  • Krauel L, Fenollosa F, Riaza L, Pérez M, Tarrado X, Morales-La Madrid A, Gomà J and Mora J.

    Use of 3D Prototypes for Complex Surgical Oncologic Cases

    WORLD JOURNAL OF SURGERY . 40(4): 889-894. Nº de cites: 40

    [doi:10.1007/s00268-015-3295-y]

  • Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH, Twisk JW, Anderson AK, Coombes L, Breen M, Hargrave OJ, Hemsley J, Craig F, Cruz-Martínez O, Kaspers GJ, van Vuurden DG, Hargrave DR and SIOPE DIPG Network.

    Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.

    Neuro-Oncology . 18(4): 582-588. Nº de cites: 19

    [doi:10.1093/neuonc/nov250]

  • Morales-La Madrid A, Hashizume R and Kieran MW.

    Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic.

    Frontiers in oncology . 5: 148-148. Nº de cites: 48

    [doi:10.3389/fonc.2015.00148]

  • Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales-La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW and Manley PE.

    Long-Term Outcome of 4,040 Children Diagnosed With Pediatric Low-Grade Gliomas: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database

    PEDIATRIC BLOOD & CANCER . 61(7): 1173-1179. Nº de cites: 204

    [doi:10.1002/pbc.24935]

  • Stricker T, Morales-La Madrid A, Chlenski A, Guerrero L, Salwen, Helen R., Gosiengfiao Y, Perlman E, Furman W, Bahrami A, Shohet, Jason M., Zage P, Hicks J, Shimada, Hiroyuki, Suganuma R, Park J, So S, London W, Pytel P, Maclean K and Cohn S.

    Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter (TM) system

    MOLECULAR ONCOLOGY . 8(3): 669-678. Nº de cites: 29

    [doi:10.1016/j.molonc.2014.01.010]

  • Morales-La Madrid A, Campbell N, Smith S, Cohn S and Salgia R.

    Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (vol 7, pg 199, 2012)

    TARGETED ONCOLOGY . 8(4): 301-301.

    [doi:10.1007/s11523-013-0291-8]